Contact
searchSearch
HMP Global

May 2012 - FRMC

Department

Conference Insider
Improving Adherence in Patients with Chronic Conditions
05/25/2012
Tori Socha
San Francisco—Poor adherence to medication regimens is a growing problem in the United States. At a Managed Care Essentials session at the AMCP meeting, representatives from CVS Caremark presented a session titled Advancing Adherence and the...
San Francisco—Poor adherence to medication regimens is a growing problem in the United States. At a Managed Care Essentials session at the AMCP meeting, representatives from CVS Caremark presented a session titled Advancing Adherence and the...
San Francisco—Poor adherence to...
05/25/2012
First Report Managed Care
Conference Insider
Tumor Necrosis Factor Inhibitors in Patients with Psoriatic Arthritis
05/24/2012
Tori Socha
San Francisco—Due to a lack of head-to-head studies demonstrating the comparative effectiveness of tumor necrosis factor inhibitors (TNFi), only indirect comparisons can be made, according to researchers. The National Institute for Health and...
San Francisco—Due to a lack of head-to-head studies demonstrating the comparative effectiveness of tumor necrosis factor inhibitors (TNFi), only indirect comparisons can be made, according to researchers. The National Institute for Health and...
San Francisco—Due to a lack of...
05/24/2012
First Report Managed Care
Anticoagulation Use in Patients with Atrial Fibrillation
05/25/2012
Tim Casey
San Francisco—Patients with atrial fibrillation (AF), providers, and health plans may benefit from utilizing software that identifies people who are at high risk of stroke, according to a descriptive, retrospective analysis of a comprehensive...
San Francisco—Patients with atrial fibrillation (AF), providers, and health plans may benefit from utilizing software that identifies people who are at high risk of stroke, according to a descriptive, retrospective analysis of a comprehensive...
San Francisco—Patients with...
05/25/2012
First Report Managed Care
Challenges and Emerging Treatments in Schizophrenia
05/25/2012
Jill Sederstorm
San Francisco—Current antipsychotic medications used to treat Schizophrenia are associated with limited efficacy and adverse events; however, treatment of the disease may be improved by new drugs on the horizon or medication therapy...
San Francisco—Current antipsychotic medications used to treat Schizophrenia are associated with limited efficacy and adverse events; however, treatment of the disease may be improved by new drugs on the horizon or medication therapy...
San Francisco—Current...
05/25/2012
First Report Managed Care
Hepatitis C Prevalence and Cost a Greater Burden in Younger Medicare Population
05/25/2012
Mary Mihalovic
San Francisco—The prevalence of hepatitis C (HCV), including advanced liver disease (ALD), and the costs to treat these conditions increased significantly among Medicare patients >65 years of age, according to information presented during...
San Francisco—The prevalence of hepatitis C (HCV), including advanced liver disease (ALD), and the costs to treat these conditions increased significantly among Medicare patients >65 years of age, according to information presented during...
San Francisco—The prevalence of...
05/25/2012
First Report Managed Care
Treatment Persistence among Insulin Glargine Users
05/25/2012
Kevin L. Carter
San Francisco—For insulin-dependent patients with type 2 diabetes mellitus (T2DM), treatment persistence may be critical in maintaining glycemic control. Poor treatment and adherence to treatment plan is associated with poor clinical...
San Francisco—For insulin-dependent patients with type 2 diabetes mellitus (T2DM), treatment persistence may be critical in maintaining glycemic control. Poor treatment and adherence to treatment plan is associated with poor clinical...
San Francisco—For...
05/25/2012
First Report Managed Care
Tools
Exploratory Web-Based SMARTI-I Tool Facilitates Drug Safety, Tolerability Evaluations
05/25/2012
Kristina Woodworth
San Francisco – Researchers from Teva Pharmaceuticals have developed a web-based Safety Monitoring and Reported Tolerability Issues Index (SMARTI-I) system to help identify safety and tolerability issues, especially during formulary decision...
San Francisco – Researchers from Teva Pharmaceuticals have developed a web-based Safety Monitoring and Reported Tolerability Issues Index (SMARTI-I) system to help identify safety and tolerability issues, especially during formulary decision...
San Francisco – Researchers from...
05/25/2012
First Report Managed Care
Growth in the Specialty Drug Pipeline Continues
05/25/2012
Eileen Koutnik-Fotopoulos
San Francisco—The specialty market continues to see a significant rate of growth due to broader use of specialty medications to treat common and rare diseases. Aimee Tharaldson, PharmD, senior clinical consultant, emerging therapeutics, at...
San Francisco—The specialty market continues to see a significant rate of growth due to broader use of specialty medications to treat common and rare diseases. Aimee Tharaldson, PharmD, senior clinical consultant, emerging therapeutics, at...
San Francisco—The specialty...
05/25/2012
First Report Managed Care
Pharmacy’s Role in the Patient-Centered Medical Home
05/24/2012
Ken Palmer
San Francisco–There are numerous key benefits of integrating a pharmacy service into a patient-centered medical home (PCMH) or accountable care organization. Among them are lowering costs through collaborative patient care and improved...
San Francisco–There are numerous key benefits of integrating a pharmacy service into a patient-centered medical home (PCMH) or accountable care organization. Among them are lowering costs through collaborative patient care and improved...
San Francisco–There are numerous...
05/24/2012
First Report Managed Care
Real-World Costs of Biologic Agents for Rheumatoid Arthritis
05/24/2012
Mary Beth Nierengarten
San Francisco—When assessing the treatment costs of biologic agents used to treat patients with rheumatoid arthritis (RA), health plans should calculate reimbursed dollars plus patient copayments rather than wholesale acquisitions costs...
San Francisco—When assessing the treatment costs of biologic agents used to treat patients with rheumatoid arthritis (RA), health plans should calculate reimbursed dollars plus patient copayments rather than wholesale acquisitions costs...
San Francisco—When assessing the...
05/24/2012
First Report Managed Care

Behind the Bill

Behind the Bill
SCOTUS Takes on the Nondelegation Doctrine: Surprising Reactions and What They Mean for Agency Power
04/02/2025
Katie Hayes, MJ
The Supreme Court recently heard arguments in Federal Communication Commission (FCC) v Consumers’ Research, a case that I covered in February and one that could dramatically reshape federal agency authority through the nondelegation...
The Supreme Court recently heard arguments in Federal Communication Commission (FCC) v Consumers’ Research, a case that I covered in February and one that could dramatically reshape federal agency authority through the nondelegation...
The Supreme Court recently heard...
04/02/2025
First Report Managed Care
Behind the Bill
Dr Oz’s Prescription for Making Medicaid “Viable at Every Level”
03/26/2025
Katie Hayes, MJ
On Tuesday, March 25, 2025, the Senate Finance Committee voted to advance Dr Mehmet Oz in his confirmation as the next head of the Centers for Medicare and Medicaid Services (CMS).1 The full Senate vote is expected “soon” (whatever that...
On Tuesday, March 25, 2025, the Senate Finance Committee voted to advance Dr Mehmet Oz in his confirmation as the next head of the Centers for Medicare and Medicaid Services (CMS).1 The full Senate vote is expected “soon” (whatever that...
On Tuesday, March 25, 2025, the...
03/26/2025
First Report Managed Care
Behind the Bill
The $880 Billion Question Continues: Dr Oz's Confirmation and the Future of Medicaid
03/19/2025
Katie Hayes, MJ
Last week, I explored the $880 billion question facing Congress—whether lawmakers could achieve their budget goals without cutting Medicaid. This week, that question took center stage as Dr Mehmet Oz, President Trump's nominee to lead the...
Last week, I explored the $880 billion question facing Congress—whether lawmakers could achieve their budget goals without cutting Medicaid. This week, that question took center stage as Dr Mehmet Oz, President Trump's nominee to lead the...
Last week, I explored the $880...
03/19/2025
First Report Managed Care
Behind the Bill
The $880 Billion Question: Can Congress Cut Spending Without Touching Medicaid?
03/12/2025
Katie Hayes, MJ
I’d like to step away from administrative law for a moment to provide a quick update on Medicaid. With news coming from all sides, what does the future of Medicaid actually look like? The House of Representatives narrowly passed a budget...
I’d like to step away from administrative law for a moment to provide a quick update on Medicaid. With news coming from all sides, what does the future of Medicaid actually look like? The House of Representatives narrowly passed a budget...
I’d like to step away from...
03/12/2025
First Report Managed Care
Behind the Bill
RFK Jr’s Public Comment Ban: The Silent Shift in Health Care Rulemaking
03/05/2025
Katie Hayes, MJ
The erosion of administrative law continues, and with it, the dismantling of decades-long precedent. In June, the Supreme Court overturned a 40-year-old doctrine that allowed federal agencies to interpret their own ambiguous statutes. Later...
The erosion of administrative law continues, and with it, the dismantling of decades-long precedent. In June, the Supreme Court overturned a 40-year-old doctrine that allowed federal agencies to interpret their own ambiguous statutes. Later...
The erosion of administrative...
03/05/2025
First Report Managed Care
Behind the Bill
Prevention Over Pills? The First 2 Weeks of Health Care’s New Direction
02/26/2025
Katie Hayes, MJ
The dust has barely settled from Robert F Kennedy Jr’s confirmation as Secretary of Health and Human Services (HHS), but the changes are already coming fast and furious—a key theme of the Trump Administration’s actions within the last several...
The dust has barely settled from Robert F Kennedy Jr’s confirmation as Secretary of Health and Human Services (HHS), but the changes are already coming fast and furious—a key theme of the Trump Administration’s actions within the last several...
The dust has barely settled from...
02/26/2025
First Report Managed Care
Behind the Bill
The Nondelegation Doctrine: The Next Constitutional Showdown (Part 2)
02/19/2025
Katie Hayes, MJ
Last week, I explored the potential revival of the nondelegation doctrine through Federal Communication Commission v Consumers’ Research. Today, I want to examine what this could mean for health care regulation by considering the parallels...
Last week, I explored the potential revival of the nondelegation doctrine through Federal Communication Commission v Consumers’ Research. Today, I want to examine what this could mean for health care regulation by considering the parallels...
Last week, I explored the...
02/19/2025
First Report Managed Care
Behind the Bill
The Nondelegation Doctrine: The Next Constitutional Showdown (Part 1)
02/12/2025
Katie Hayes, MJ
Just when you thought the dust had settled from the Chevron decision, the Supreme Court is gearing up to hear arguments in Federal Communications Commission v Consumers' Research next month, potentially reviving the long-dormant nondelegation...
Just when you thought the dust had settled from the Chevron decision, the Supreme Court is gearing up to hear arguments in Federal Communications Commission v Consumers' Research next month, potentially reviving the long-dormant nondelegation...
Just when you thought the dust...
02/12/2025
First Report Managed Care
Behind the Bill
No, President Trump Did Not Actually Sign an Executive Order That Would Increase Drug Costs for Beneficiaries
02/05/2025
Katie Hayes, MJ
On inauguration day, President Trump issued an executive order rescinding several Biden-era health care initiatives, including 3 experimental drug pricing models developed by the Center for Medicare and Medicaid Innovation (CMMI). Oh boy did...
On inauguration day, President Trump issued an executive order rescinding several Biden-era health care initiatives, including 3 experimental drug pricing models developed by the Center for Medicare and Medicaid Innovation (CMMI). Oh boy did...
On inauguration day, President...
02/05/2025
First Report Managed Care
Behind the Bill
Robert F. Kennedy Jr’s Confirmation and the Unexpected Turn in the Drug Pricing Debate
01/29/2025
Katie Hayes, MJ
The Plot Thickens in Drug Pricing Drama Just when you thought the drug pricing debate couldn't get more interesting, Robert F. Kennedy Jr adds an unexpected twist. During closed-door Senate meetings, President Trump’s US Department of...
The Plot Thickens in Drug Pricing Drama Just when you thought the drug pricing debate couldn't get more interesting, Robert F. Kennedy Jr adds an unexpected twist. During closed-door Senate meetings, President Trump’s US Department of...
The Plot Thickens in Drug...
01/29/2025
First Report Managed Care

Subscribe and Stay Ahead With Daily Industry Insights

First Report Managed Care Newsletter

Trending Articles

Elizabeth Brem University of California Irvine
Videos
Analyzing Patient Selection and the Utility of CNS Prophylaxis for Patients With DLBCL
04/20/2023
In a debate at the 2023 Great Debates & Updates in Hematologic Malignancies conference in New York, New York, Elizabeth A. Brem, MD, analyzed the role of central nervous system prophylaxis for patients with DLBCL.
In a debate at the 2023 Great Debates & Updates in Hematologic Malignancies conference in New York, New York, Elizabeth A. Brem, MD, analyzed the role of central nervous system prophylaxis for patients with DLBCL.
In a debate at the 2023 Great...
04/20/2023
Oncology
News
Thousands Face Medicaid Coverage Disruptions in South Dakota and North Carolina
05/18/2023
Arielle Zionts
Now that the public health emergency has expired, individuals may lose coverage but then requalify several months later in states which have recently approved Medicaid expansion.
Now that the public health emergency has expired, individuals may lose coverage but then requalify several months later in states which have recently approved Medicaid expansion.
Now that the public health...
05/18/2023
First Report Managed Care
News
Digital Therapeutics "Viable Solution" for Mental Health Needs
06/07/2023
Jolynn Tumolo
“The participants were willing to utilize digital therapeutics if available, and even preferred this type of support compared to actually visiting a clinic,” researchers wrote.
“The participants were willing to utilize digital therapeutics if available, and even preferred this type of support compared to actually visiting a clinic,” researchers wrote.
“The participants were willing...
06/07/2023
First Report Managed Care
News
First Gene Therapy for Severe Hemophilia A Is Approved
06/29/2023
Amanda Balbi
This approval comes after a safety and effectiveness trial showed that the treatment improved participants’ annualized bleeding rate after 3 years.
This approval comes after a safety and effectiveness trial showed that the treatment improved participants’ annualized bleeding rate after 3 years.
This approval comes after a...
06/29/2023
First Report Managed Care
Stock image of a doctor holding a phone
Commentary
Prescription Digital Therapeutics: Ongoing Efforts to Expand Awareness, Integrate Into Clinical Practice
07/28/2023
Yvette C. Terrie, BS Pharm, RPh
Yvette Terrie shares digital therapeutic updates regarding FDA approvals, recent and upcoming clinical trials, and current industry regulations.
Yvette Terrie shares digital therapeutic updates regarding FDA approvals, recent and upcoming clinical trials, and current industry regulations.
Yvette Terrie shares digital...
07/28/2023
First Report Managed Care

May 2012 Volume 9 Issue 5

View Issue Archive
Editorial Correspondence

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use